News

Medical Dialogues6h
Low Doses of 5-ARIs Linked to Higher Suicide Risk, Lower Cardiovascular Mortality: Study Finds
South Korea: New data on 5α-reductase inhibitors (5-ARIs) reveals that low cumulative doses are associated with an increased ...
Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory ...